| Name | 3,4-Dimethoxy-N-[4-(3-nitrophenyl)-5-(1-piperidinylmethyl)-1,3-th iazol-2-yl]benzenesulfonamide |
|---|---|
| Synonyms |
3,4-Dimethoxy-N-[4-(3-nitrophenyl)-5-(1-piperidinylmethyl)-2-thiazolyl]-benzenesulfonamide
JM6 |
| Description | JM6 is a weak kynurenine 3-monooxygenase (KMO) inhibitor with an IC50 of 19.85 μM for mouse KMO. JM6 can be used for Alzheimer's diseases research[1]. |
|---|---|
| Related Catalog | |
| Target |
IC50: 19.85 μM (kynurenine 3-monooxygenase)[1] |
| References |
| Molecular Formula | C23H26N4O6S2 |
|---|---|
| Molecular Weight | 518.60600 |
| Exact Mass | 518.12900 |
| PSA | 163.20000 |
| LogP | 6.13710 |
| Symbol |
GHS06 |
|---|---|
| Signal Word | Danger |
| Hazard Statements | H301 |
| Precautionary Statements | P301 + P310 |
| RIDADR | UN 2811 6.1 / PGIII |